Hap Trading, LLC Sorrento Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	SELL	$0.74 - $1.83 $370 - $915	-500 Reduced 4.5%	10,600 $55,000
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $16,761 - $31,968	11,100 New	11,100 $48,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $46,500 - $72,300	10,000 Added 31.85%	41,400 $114,000
Q3 2021 Nov 10, 2021	BUY	$7.41 - $10.99 $43,719 - $64,841	5,900 Added 23.14%	31,400 $66,000
Q2 2021 Aug 11, 2021	SELL	$6.35 - $10.0 $75,565 - $119,000	-11,900 Reduced 31.82%	25,500 $46,000

Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $114,589 - $269,113	-16,300 Reduced 30.35%	37,400 $91,000
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $104,256 - $216,295	-18,100 Reduced 25.21%	53,700 $148,000
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $190,036 - $579,656	30,800 Added 75.12%	71,800 $98,000
Q2 2020 Aug 10, 2020	BUY	$1.73 - $6.76 $70,930 - $277,160	41,000 New	41,000 $32,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.